Latest Antiplatelet drug Stories
Clinical Risk Assessment Plus Platelet Function Testing Identifies High-Risk Patients in Whom a Tailored Approach to Potent Antiplatelet Treatment May Potentially Be Beneficial SAN
Compared to Clopidogrel, Prasugrel Did Not Have a Higher Risk of Bleeding at 90 Days SAN DIEGO, May 8, 2015 /PRNewswire/ -- Prasugrel (Effient®) is more likely to be given to lower-risk
New Study Finds Ticagrelor Works More Quickly When Given at the Time of PCI SAN DIEGO, May 7, 2015 /PRNewswire/ -- Antiplatelet drug ticagrelor (Brilinta®) works faster and is more
- - FDA clears investigational new drug submission NASHVILLE, Tenn., Feb. 11, 2015 /PRNewswire/ -- Cumberland Pharmaceuticals Inc.
- RE-VERSE AD(TM) is being conducted in more than 35 countries with aim to enroll 250 patients RIDGEFIELD, Conn., Nov. 10, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
Emergency Department-Based Observational Study Aims to Fill Data Gaps in ACS Care Shrewsbury, NJ (PRWEB) October 27, 2014 The Hospital Quality Foundation
ZWOLLE, The Netherlands, June 12, 2014 /PRNewswire/ -- Randomized Evaluation of short-term DUal antiplatelet therapy in patients with acute coronary syndrome treated with
Rapid CYP2C19 Testing for Personalized Antiplatelet Therapy in 600-Patient Clinical Trial with Spartan Bioscience (PRWEB) March 18, 2014 Spartan Bioscience
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.